With serum iron 49 µg/dL, transferrin saturation 13% (low), and total iron‑binding capacity 366 µg/dL (low), what is the likely diagnosis and how should I evaluate and manage the patient?

Likely Diagnosis: Iron Deficiency Anemia with Possible Chronic Disease Component

This patient has iron deficiency anemia, evidenced by low transferrin saturation (13%) and low serum iron (49 µg/dL), and requires immediate evaluation for gastrointestinal blood loss and assessment of ferritin levels to guide iron replacement therapy. 1

Diagnostic Interpretation

Iron Parameters Analysis

• Low transferrin saturation (13%) indicates insufficient iron available for erythropoiesis, as TSAT represents iron available to the bone marrow for red blood cell production 1

• Low serum iron (49 µg/dL) is independently associated with anemia risk, even when TSAT might be misleadingly normal in certain contexts 2

• Low TIBC (366 µg/dL) is atypical for pure iron deficiency, which typically shows elevated TIBC; this suggests a possible concurrent chronic disease state, malnutrition, or inflammation 2

Key Diagnostic Consideration

The combination of low TSAT with low TIBC creates a diagnostic challenge. In pure iron deficiency, TIBC should be elevated (>400 µg/dL). Low TIBC is associated with hypoalbuminemia and elevated C-reactive protein, suggesting inflammation or malnutrition may be contributing 2. However, the low TSAT and low serum iron still indicate true iron deficiency requiring treatment 1, 2.

Immediate Evaluation Required

Essential Laboratory Tests

• Serum ferritin is the preferred initial diagnostic test and must be obtained immediately 3

  • Ferritin <25 ng/mL in males or <11 ng/mL in females confirms insufficient iron stores 1
  • Ferritin between 46-99 ng/mL may require additional testing including serum transferrin receptor or bone marrow biopsy 3
  • Note that ferritin is an acute-phase reactant and may be falsely elevated with inflammation 1, 4

• Complete blood count with indices to assess:

  • Mean corpuscular volume (MCV) - expect microcytic anemia if iron deficiency is established 1
  • Hemoglobin level to quantify anemia severity 1
  • Reticulocyte count to assess bone marrow response 1

• Inflammatory markers (albumin, C-reactive protein) to explain the low TIBC and assess for anemia of chronic disease 2

Critical Clinical Evaluation

• Assess for gastrointestinal bleeding - this is mandatory in patients with iron deficiency who are not menstruating women and have no other obvious blood loss 1

  • Fecal occult blood testing
  • Consider endoscopic evaluation (colonoscopy first if age >50 years) 3
  • Nine percent of patients older than 65 years with iron deficiency anemia have gastrointestinal cancer 3

• Evaluate for chronic kidney disease given the low TIBC pattern:

  • Serum creatinine and estimated GFR 1
  • Urinalysis 1

• Assess nutritional status and dietary iron intake 2

• Review medications that may cause occult bleeding (NSAIDs, anticoagulants) 3

Management Strategy

Iron Replacement Therapy

Initiate oral iron supplementation immediately while completing the diagnostic workup, unless contraindications exist 3:

• Dosing: Ferrous sulfate 325 mg (65 mg elemental iron) orally 2-3 times daily 3

• Response monitoring: Check hemoglobin at one month 3

  • Expect 1-2 g/dL increase in hemoglobin if treatment is effective 3
  • Failure to respond suggests malabsorption, continued bleeding, or an unidentified lesion 3

When to Consider Intravenous Iron

• Malabsorption of oral iron 3
• Intolerance to oral iron (gastrointestinal side effects)
• Ongoing blood loss exceeding oral replacement capacity
• Chronic kidney disease with functional iron deficiency 1

Special Considerations for CKD Patients

If chronic kidney disease is identified:

• Target TSAT >20% and ferritin levels appropriate for CKD stage 1
• Consider that transferrin saturation may be less reliable in CKD with inflammation, and serum iron levels provide additional valuable information 5
• Patients with normal TSAT but low serum iron remain at risk for anemia and may benefit from iron therapy 2
• Newer markers (reticulocyte hemoglobin content, percentage of hypochromic red cells) may be helpful when ferritin and TSAT are discordant, though not widely available 1, 4

Common Pitfalls to Avoid

• Do not delay gastrointestinal evaluation in non-menstruating patients with iron deficiency - malignancy must be excluded 1, 3

• Do not rely solely on TSAT when TIBC is low; the inflammatory state alters iron metabolism and TSAT becomes a poorer index of iron availability 5

• Do not assume adequate iron stores based on normal or high ferritin alone in the setting of inflammation - ferritin may be falsely elevated 1, 4

• Do not overlook low serum iron even if TSAT appears borderline normal - low serum iron independently predicts anemia risk 2